Podcast appearances and mentions of Barbara Sahakian

This time, we're looking at gambling addiction and the associated harms. We hear from Bianca, a recovering gambling addict, about the deceit which characterised her experiences with betting, and why this is shared by many like here. Then, with Barbara Sahakian from the University of Cambridge, we learn about the biological and environmental factors which may lead to problem gambling, and hear from the perspective of the industry with Dan Waugh of Regulus. Finally, what treatments are out there for gambling addiction? Emma Ryan from the UK's first Primary Care Gambling Service tells us. Like this podcast? Please help us by supporting the Naked Scientists

Cambridge University neuropsychologist Professor Barbara Sahakian talks about new research from her team using data from the UK biobank to reach conclusions about mental health. The study used neuroimaging to see the differences in the brain, changing volumes of areas like the hippocampus, vital for memory and learning, and the amygdala, for emotional regulation.   At last count more than 12% of New Zealanders were on antidepressants, 16% of females, 9% of males, 22% of women over age 65. We asked Barbara Sahakian about her latest findings.  [picture id="4MLTFVV_copyright_image_244774" crop="16x10" layout="full"] 

Introduction and News Topic: 1 World Heart Day Topic: 2 Depression can be prevented with a healthy lifestyle Guest Includes: Professor Antoniades Charis Dr Amam Mbakwem Project Manager: Joanna Heath Tas Amin Prof. Barbara Sahakian

The earlier that children start reading for enjoyment, the better it is for their verbal learning, memory, and speech development. A Cambridge University study has found a strong link between reading for pleasure at a young age and school performance later. They're also less stressed, they behave better, they spend less time on screens, and they sleep more soundly. The research used a large database of young people in the United States. One of the report's authors, neuropsychologist Dr Barbara Sahakian is a professor in the department of psychiatry at the University of Cambridge.

Prof. Barbara Sahakian discusses the associations of social isolation and loneliness with later dementia. Show references: https://n.neurology.org/content/99/2/e164.abstract This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Gregg Day talks with Prof. Barbara Sahakian about the associations of social isolation and loneliness with later dementia. Read the full article in Neurology. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

New research out from the University of Cambridge suggests that we should all be aiming for exactly seven hours' sleep, from our thirties to old age. Barbara Sahakian, Professor of Clinical Neuropsychology at the University of Cambridge joined Kieran to explain the science behind a good nights sleep.

Alan speaks with Barbara Sahakian, Professor of Clinical Neuropsychology, University of Cambridge, about doomscrolling and how it impacts your health.

What causes dementia? And how do we diagnose and treat it? Is there anything we can do to stop ourselves from developing dementia? These are the crucial questions we'll be exploring with clinical neuropsychologist Barbara Sahakian, sociologist Richard Milne, and neurologist James Rowe. In this episode, we'll find out more about what dementia actually is, some surprising factors that increase a person's risk of developing dementia, and computer games that can actually help detect and diagnose dementia.This episode was produced by Nick Saffell, James Dolan, Naomi Clements-Brod and Annie Thwaite. Please take our survey!How did you find us? What do you like about Mind Over Chatter? We want to know. So we put together this survey https://forms.gle/r9CfHpJVUEWrxoyx9. If you could please take a few minutes to fill it out, it would be a big help. Timestamps: [00:00] - Introductions[01:10] - A bit about the guests' research[02:20] - Defining dementia and what causes it[03:10] - Dementia and Alzehiemers [03:10] - What we mean by the term neurodegenerative and tau proteins [04:15] - How Dementia is different from normal aging [05:15] - Who does dementia impact and the number of people in the UK who have dementia[05:45] - One in three will get dementia. One in six over the age of 80 have dementia in the UK. WHO estimates 55 million people worldwide and this figure is set to rise to 78 million by 2030. [07:10] -The impact on families and carers. What is the cost to the economy? Trillions globally. [08:45] - The lifespan of dementia. How the combination of our genes puts us at a higher or lower risk of dementia. How this proceeds through adult life. [10:20] - Normal ageing vs dementia [12:35] - Time for a recap! [16:40] - How do we detect dementia? Declines in cognition and the importance of episodic memory. [18:35] - CANTAB: a tool to detect early Alzheimer's disease[20:05] - Establishing the value of early detection and early diagnosis. [21:10] - APOE tests and the debate around if early diagnosis is useable information. Does it cause more worry and anxiety? What can be people do with the information? [23:00] - Does this argument focus too much on the stigma associated with dementia. We should all want to know as we can do something around our own personal risk. [24:40] - Should these risk factors simply be explained as steps that we should do anyway. Do we have to be given information about risk?[25:15] - How can we reduce our risk of dementia? Early detection also allows people more time to get some treatments and their finances together. [27:10] - Is there a way to look for the clumps of proteins in your brain? Physical test options. [27:40] - it is less about technology. The bigger question is about how we use the information to reduce personal risk. Diagnosis, screening and preventative interventions. [29:30] - The possibility for behaviour change? How do we put in place systems that change behaviour. Policy and health system change. [31:00] - The risk factors - depression, social isolation, hearing loss, cognitive inactivity, air pollution. [31:30] - Time for another recap! [36:40] - Dementia isn't just a problem for people over the age of 65. 42,000...

We're looking ahead to the science coming up in 2021! From the Large Hadron Collider restarting, to the USA likely rejoining the Paris climate agreement, to - hopefully - an end to the pandemic. Plus, we're making some new year's resolutions that are going to last... Like this podcast? Please help us by supporting the Naked Scientists

We're looking ahead to the science coming up in 2021! From the Large Hadron Collider restarting, to the USA likely rejoining the Paris climate agreement, to - hopefully - an end to the pandemic. Plus, we're making some new year's resolutions that are going to last... Like this podcast? Please help us by supporting the Naked Scientists

Barbara Sahakian is Professor of Clinical Neuropsychology at Cambridge, Past-President of the International Neuroethics Society, Past-President of the British Association for Psychopharmacology, and a Fellow of the Academy of Medical Sciences. In this talk, she discusses her book "Sex, Lies, and Brain Scans: How fMRI Reveals What Really Goes on in Our Minds". With co-author Julia Gottwald, she takes readers beyond the media headlines, considering what the technique of fMRI entails, and what information it can give us. They show which applications are possible today, which ones are science fiction, and also discuss the important ethical questions these techniques raise. Get the book here: https://goo.gle/3ac8zRu. Visit https://g.co/talksatgoogle/barbarasahakian to watch the video.   

A cross-party remain alliance successfully tied Boris Johnson's hands in parliament last week, but with a general election looming, will this unlikely coalition last (00:30)? We also find out about ‘study drugs' – what are the little blue pills that American students are turning to (17:35)? And last, is Boris Johnson anything like his classical heroes (31:00)?With Katy Balls, Polly Mackenzie, Madeleine Kearns, Dr Barbara Sahakian, Harry Mount, and Daisy Dunn.Presented by Cindy Yu and Isabel Hardman.Produced by Cindy Yu and Adam Cherry.

A cross-party remain alliance successfully tied Boris Johnson’s hands in parliament last week, but with a general election looming, will this unlikely coalition last (00:30)? We also find out about ‘study drugs’ – what are the little blue pills that American students are turning to (17:35)? And last, is Boris Johnson anything like his classical heroes (31:00)? With Katy Balls, Polly Mackenzie, Madeleine Kearns, Dr Barbara Sahakian, Harry Mount, and Daisy Dunn. Presented by Cindy Yu and Isabel Hardman. Produced by Cindy Yu and Adam Cherry.

The world we live in today can be described as a knowledge economy, a world driven by brain-power, revolving around creativity and intellect.  What if somebody told you that taking a pill could elevate your thinking? With the swallow of a tablet, you could become a smarter, quicker, more creative person-- would you take that chance? In this episode, we have Dr. Barbara Sahakian with us to talk about cognitive enhancing drugs and their ever-increasing relevance in our lives: what are they? What do they do? How do they work? And should we try them? Dr. Sahakian is currently one of the world’s leading experts in the field of neuroscience, having received the Distinguished International Scholar Award at the University of Pennsylvania in 2009 and in 2015, and awarded a Doctor of Science degree from the University of Cambridge, which is the highest degree awarded by the University for distinguished research in science- naming only a few of her many accomplishments. Should healthy people take cognitive enhancing drugs to improve their performance? Before taking your next Adderall popping some Ritalin, or experimenting with Modafinil, we invite you to give this episode a listen. Hear what the expert has to say and let that inform your decision. Shownotes and more at EducationLawyers.com/SundaySchool  

Millions of people worldwide are affected by Alzheimer's Disease; Terry Pratchett was famously a victim of the condition, which progressively robs sufferers of their mental faculties. At the moment, no therapies are available to halt the disease, but it might be possible to keep patients functioning well, for longer, with a bit of brain-training. Cambridge University neuroscientists have invented a memory-boosting app called GameShow. Katie Haylor went to see the game's co-inventor Barbara Sahakian and lead scientist George Savulich... Like this podcast? Please help us by supporting the Naked Scientists

Millions of people worldwide are affected by Alzheimer's Disease; Terry Pratchett was famously a victim of the condition, which progressively robs sufferers of their mental faculties. At the moment, no therapies are available to halt the disease, but it might be possible to keep patients functioning well, for longer, with a bit of brain-training. Cambridge University neuroscientists have invented a memory-boosting app called GameShow. Katie Haylor went to see the game's co-inventor Barbara Sahakian and lead scientist George Savulich... Like this podcast? Please help us by supporting the Naked Scientists

Are our brains hardwired to be left-wing or right-wing? How did mental health become a hot political issue? What advice can brain scientists give politicians to help get their message across? This week David interviews Professor Barbara Sahakian – the renowned neuropsychologist who has worked with the U.K. government on questions of mental health and well-being – to discover the lessons of new scientific research for our politics. The team then discuss the Labour and Conservative manifestos and the inner tensions they reveal within the parties, and what their pledges really mean in an age of coalitions and compromise. And, in the week when Hilary Clinton declared her presidential candidacy, we debate the time spans of political campaigns in the UK and the U.S., and the different ways the two countries do politics. See acast.com/privacy for privacy and opt-out information.

Meet Brian, the robot programmed to help look after the elderly. Plus we explore the role of robots in combat and in the classroom and we explore the ethics of how science shapes society. This special Naked Neuroscience podcast series, supported by the Wellcome Trust, reports from the International Neuroethics Society annual meeting at the AAAS headquarters in Washington DC and features guest robots Brian, Casper and Tangy, as well as human contributors Goldie Nejat, Barbara Sahakian, Paul Root Wolpe and James Giordano. Like this podcast? Please help us by supporting the Naked Scientists

Meet Brian, the robot programmed to help look after the elderly. Plus we explore the role of robots in combat and in the classroom and we explore the ethics of how science shapes society. This special Naked Neuroscience podcast series, supported by the Wellcome Trust, reports from the International Neuroethics Society annual meeting at the AAAS headquarters in Washington DC and features guest robots Brian, Casper and Tangy, as well as human contributors Goldie Nejat, Barbara Sahakian, Paul Root Wolpe and James Giordano. Like this podcast? Please help us by supporting the Naked Scientists

Millions invested in brain research across the globe. It's the decade of the brain. But how will the results shape our future societies? Like this podcast? Please help us by supporting the Naked Scientists

Millions invested in brain research across the globe. It's the decade of the brain. But how will the results shape our future societies? Like this podcast? Please help us by supporting the Naked Scientists

Why are some psychiatric illnesses, like anxiety and depression, on the increase? Could conditions, like attention deficit hyperactivity disorder, or ADHD, confer an evolutionary advantage? And is it ethical to screen babies for future brain disorders? Like this podcast? Please help us by supporting the Naked Scientists

Why are some psychiatric illnesses, like anxiety and depression, on the increase? Could conditions, like attention deficit hyperactivity disorder, or ADHD, confer an evolutionary advantage? And is it ethical to screen babies for future brain disorders? Like this podcast? Please help us by supporting the Naked Scientists

Smart Drugs

On Start the Week Jonathan Freedland journeys from the origin of life to the possibilities of new life-forms with the geneticist Adam Rutherford. Steve Jones updates the Bible from the point of view of modern science and Barbara Sahakian looks at our ability to make decisions, and whether 'smart drugs' should be used to boost our reactions. The artist Susan Aldworth is inspired by neuro-scientific imagery to explore the relationship between mind and body in her portraits of those with epilepsy and in doing so asks how this material corresponds or contrasts with the subject's sense of self. Producer: Natalia Fernandez.

Could genetics pave the way for developing schizophrenia or Alzheimer 's disease? Is there a genetic link between optimism and obesity? Is it ethical to screen people's DNA? Plus we find out what a nap might do for your memory, how a new study is turning addiction treatment on its head and we unravel what it means to be human. Plus we unzip whether DNA might make for an extremely high IQ! Like this podcast? Please help us by supporting the Naked Scientists

Could genetics pave the way for developing schizophrenia or Alzheimer 's disease? Is there a genetic link between optimism and obesity? Is it ethical to screen people's DNA? Plus we find out what a nap might do for your memory, how a new study is turning addiction treatment on its head and we unravel what it means to be human. Plus we unzip whether DNA might make for an extremely high IQ! Like this podcast? Please help us by supporting the Naked Scientists

We find out exactly what is going on in the brain during the teenage years. Plus we ask should we all be taking drugs to make us 'smarter'? And we find out about wiring up bats for neuroscience research and beating addiction with positive messages. Like this podcast? Please help us by supporting the Naked Scientists

We find out exactly what is going on in the brain during the teenage years. Plus we ask should we all be taking drugs to make us 'smarter'? And we find out about wiring up bats for neuroscience research and beating addiction with positive messages. Like this podcast? Please help us by supporting the Naked Scientists

Jim Al-Khalili meets Cambridge University neuroscientist Barbara Sahakian. She talks about her Life Scientific finding drugs to slow down the memory losses that happen in Alzheimer's disease. She worked in some of the first memory clinics that were set up in the US and the UK to help people who had problems remembering and has developed tests to find out if peoples' forgetfulness is the first sign of dementia. More recently she has turned her attention to drugs that can improve the performance of surgeons or pilots or other professions where it is important to be alert for long times. Barbara says that they could even be used to make us more entrepreneurial. And some students are taking them as they think they could be giving them an edge in exams. Jim and Barbara discuss the thorny ethical issues raised by these uses of these drugs.

Jim Al-Khalili meets neuroscientist Barbara Sahakian. Neurotransmitters are chemicals in the brain which effect our memory and understanding, and neuropharmacology is the study of drugs which can be used in conditions like Alzheimer's disease or depression. But can new treatments improve the performance of surgeons or pilots and could they even be used to make us more entrepreneurial?

Andrew Marr explores the limits of science and art in this week's Start the Week. The philosopher and neuroscientist Raymond Tallis mounts an all-out assault on those who see neuroscience and evolutionary theory as holding the key to understanding human consciousness and society. While fellow scientist Barbara Sahakian explores the ethical dilemmas which arise when new drugs developed to treat certain conditions are used to enhance performance in the general population. And the gerontologist Aubrey de Grey looks to the future when regenerative medicine prevents the process of aging. Producer: Katy Hickman.